# Postmenopausal Pessary Users: Estrogen Versus Trimosan

> **NCT03943823** · PHASE4 · TERMINATED · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 4 (actual)

## Conditions studied

- Vaginosis
- Vaginosis, Bacterial
- Vaginal Discharge

## Interventions

- **DRUG:** Estrogen vaginal cream
- **DRUG:** Trimo-San vaginal gel

## Key facts

- **NCT ID:** NCT03943823
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-05-07
- **Primary completion:** 2021-03-08
- **Final completion:** 2021-04-08
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Difficulties in recruiting and retaining patients due to the COVID pandemic; lack of availability of study drug trimosan; lack of study personnel
- **Last updated:** 2023-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03943823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03943823, "Postmenopausal Pessary Users: Estrogen Versus Trimosan". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT03943823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*